Market Cap

BioMérieux SA Market Capitalization:

€11.10 Billion

EUR as of July 1, 2024

US$11.92 Billion

business BioMérieux SA Company Profile

BioMérieux SA Main Stock Listing

Euronext: BIM

Market Capitalization History of BioMérieux SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $204.45 B
Danaher $177.21 B
Siemens Healthineers AG $63.84 B
DexCom, Inc. $45.21 B
Lonza Group Ltd $39.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of BioMérieux SA market cap

Date Market Cap YoY Change
Jan. 1, 2024 €11.88 B 4.16%
Jan. 1, 2023 €11.41 B -7.06%
Jan. 1, 2022 €12.28 B -18.39%
Jan. 1, 2021 €15.04 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

BioMérieux SA Categories

France languages Healthcare languages Diagnostics & Research
France Healthcare France Diagnostics & Research

Stocks & Indices

BioMérieux SA has the following listings and related stock indices.


Stock: Euronext: BIM

Stock: FSX: EYWN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.